Celldex Therapeutics Inc
NASDAQ:CLDX

Watchlist Manager
Celldex Therapeutics Inc Logo
Celldex Therapeutics Inc
NASDAQ:CLDX
Watchlist
Price: 20.92 USD 1.01% Market Closed
Market Cap: 1.4B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

CLDX Price Targets Summary
Celldex Therapeutics Inc

Wall Street analysts forecast CLDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLDX is 58.4 USD with a low forecast of 31.31 USD and a high forecast of 94.5 USD.

CLDX Lowest Forecast
Wall Street Target
31.31 USD
50% Upside
CLDX Average Forecast
Wall Street Target
58.4 USD
179% Upside
CLDX Highest Forecast
Wall Street Target
94.5 USD
352% Upside
Lowest
Price Target
31.31 USD
50% Upside
Average
Price Target
58.4 USD
179% Upside
Highest
Price Target
94.5 USD
352% Upside
Celldex Therapeutics Inc Competitors:
Price Targets
CDNA
CareDx Inc
47% Upside
C
COYA
Coya Therapeutics Inc
211% Upside
603087
Gan & Lee Pharmaceuticals
6% Upside
E
206650
EuBiologics Co Ltd
25% Upside
CDNA
CareDx Inc
47% Upside
C
COYA
Coya Therapeutics Inc
211% Upside
603087
Gan & Lee Pharmaceuticals
6% Upside
E
206650
EuBiologics Co Ltd
25% Upside
HUMA
Humacyte Inc
260% Upside
CSL
CSL Ltd
33% Upside
BBIO
BridgeBio Pharma Inc
54% Upside
STOK
Stoke Therapeutics Inc
101% Upside

Revenue
Forecast

Revenue Estimate
Celldex Therapeutics Inc

For the last 13 years the compound annual growth rate for Celldex Therapeutics Inc's revenue is -2%. The projected CAGR for the next 3 years is 72%.

-2%
Past Growth
72%
Estimated Growth
Estimates Accuracy
16%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Celldex Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Celldex Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-88%
Average Miss
What are analyst estimates?

See Also

Summary
CLDX intrinsic value, competitors valuation, and company profile.
DCF Valuation
CLDX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CLDX stock valuation using valuation multiples.
Wall Street Estimates
CLDX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CLDX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CLDX's stock price target?
Price Target
58.4 USD

According to Wall Street analysts, the average 1-year price target for CLDX is 58.4 USD with a low forecast of 31.31 USD and a high forecast of 94.5 USD.

What is Celldex Therapeutics Inc's Revenue forecast?
Projected CAGR
72%

For the last 13 years the compound annual growth rate for Celldex Therapeutics Inc's revenue is -2%. The projected CAGR for the next 3 years is 72%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 260,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.